Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Anastrozole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Cimzia
Active Ingredient: Certolizumab pegol 200mg
Dosage Form: Solution for injection
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany
Product: Implanon NXT
Active Ingredient: Etonogestrel 68mg
Dosage Form: Subcutaneous implant
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: NV Organon, Oss, The Netherlands
Product: Lamivudine Alphapharm
Active Ingredient: Lamivudine 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India
Product: Next Choice
Active Ingredient: Levonorgestrel 0.75mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Watson Laboratories Inc, California, United States of America
Dated this 8th day of September 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).